AAAAAA

   
Results: 1-11 |
Results: 11
SUPPRESSION OF HUMAN PROSTATE CARCINOMA METASTASES IN SEVERE COMBINEDIMMUNODEFICIENT MICE BY INTERLEUKIN-2 IMMUNOCYTOKINE THERAPY
Authors: DOLMAN CS MUELLER BM LODE HN XIANG R GILLIES SD REISFELD RA
Citation: Cs. Dolman et al., SUPPRESSION OF HUMAN PROSTATE CARCINOMA METASTASES IN SEVERE COMBINEDIMMUNODEFICIENT MICE BY INTERLEUKIN-2 IMMUNOCYTOKINE THERAPY, Clinical cancer research, 4(10), 1998, pp. 2551-2557
RECOMBINANT IMMUNOCYTOKINES TARGETING THE MOUSE TRANSFERRIN RECEPTOR - CONSTRUCTION AND BIOLOGICAL-ACTIVITIES
Authors: DREIER T LODE HN XIANG R DOLMAN CS REISFELD RA KANG AS
Citation: T. Dreier et al., RECOMBINANT IMMUNOCYTOKINES TARGETING THE MOUSE TRANSFERRIN RECEPTOR - CONSTRUCTION AND BIOLOGICAL-ACTIVITIES, Bioconjugate chemistry, 9(4), 1998, pp. 482-489
IMMUNOCYTOKINES - A PROMISING APPROACH TO CANCER-IMMUNOTHERAPY
Authors: LODE HN XIANG R BECKER JC GILLIES SD REISFELD RA
Citation: Hn. Lode et al., IMMUNOCYTOKINES - A PROMISING APPROACH TO CANCER-IMMUNOTHERAPY, Pharmacology & therapeutics (Oxford), 80(3), 1998, pp. 277-292
GENE-THERAPY WITH A SINGLE-CHAIN INTERLEUKIN-12 FUSION PROTEIN INDUCES T-CELL-DEPENDENT PROTECTIVE IMMUNITY IN A SYNGENEIC MODEL OF MURINE NEUROBLASTOMA
Authors: LODE HN DREIER T XIANG R VARKI NM KANG AS REISFELD RA
Citation: Hn. Lode et al., GENE-THERAPY WITH A SINGLE-CHAIN INTERLEUKIN-12 FUSION PROTEIN INDUCES T-CELL-DEPENDENT PROTECTIVE IMMUNITY IN A SYNGENEIC MODEL OF MURINE NEUROBLASTOMA, Proceedings of the National Academy of Sciences of the United Statesof America, 95(5), 1998, pp. 2475-2480
INDUCTION OF PERSISTENT TUMOR-PROTECTIVE IMMUNITY IN MICE CURED OF ESTABLISHED COLON-CARCINOMA METASTASES
Authors: XIANG R LODE HN DREIER T GILLIES SD REISFELD RA
Citation: R. Xiang et al., INDUCTION OF PERSISTENT TUMOR-PROTECTIVE IMMUNITY IN MICE CURED OF ESTABLISHED COLON-CARCINOMA METASTASES, Cancer research, 58(17), 1998, pp. 3918-3925
NATURAL-KILLER CELL-MEDIATED ERADICATION OF NEUROBLASTOMA METASTASES TO BONE-MARROW BY TARGETED INTERLEUKIN-2 THERAPY
Authors: LODE HN XIANG R DREIER T VARKI NM GILLIES SD REISFELD RA
Citation: Hn. Lode et al., NATURAL-KILLER CELL-MEDIATED ERADICATION OF NEUROBLASTOMA METASTASES TO BONE-MARROW BY TARGETED INTERLEUKIN-2 THERAPY, Blood, 91(5), 1998, pp. 1706-1715
TARGETED INTERLEUKIN-2 THERAPY FOR SPONTANEOUS NEUROBLASTOMA METASTASES TO BONE-MARROW
Authors: LODE HN XIANG R VARKI NM DOLMAN CS GILLIES SD REISFELD RA
Citation: Hn. Lode et al., TARGETED INTERLEUKIN-2 THERAPY FOR SPONTANEOUS NEUROBLASTOMA METASTASES TO BONE-MARROW, Journal of the National Cancer Institute, 89(21), 1997, pp. 1586-1594
TARGETED CYTOKINE DELIVERY WITH RECOMBINANT ANTIBODY FUSION PROTEINS FOR THERAPEUTIC INTERVENTION
Authors: LODE HN XIANG R DREIER T GILLIES SD REISFELD RA
Citation: Hn. Lode et al., TARGETED CYTOKINE DELIVERY WITH RECOMBINANT ANTIBODY FUSION PROTEINS FOR THERAPEUTIC INTERVENTION, European journal of cancer, 33, 1997, pp. 302-302
PTCARE - A COMPUTER EXPERT-SYSTEM FOR THE MANAGEMENT OF POST PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY PATIENTS
Authors: WONG Y KANG Y XIANG R
Citation: Y. Wong et al., PTCARE - A COMPUTER EXPERT-SYSTEM FOR THE MANAGEMENT OF POST PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY PATIENTS, Journal of the American College of Cardiology, 29(2), 1997, pp. 2251-2251
ELIMINATION OF ESTABLISHED MURINE COLON-CARCINOMA METASTASES BY ANTIBODY-INTERLEUKIN-2 FUSION PROTEIN THERAPY
Authors: XIANG R LODE HN DOLMAN CS DREIER T VARKI NM QIAN XQ LO KM LAN Y SUPER M GILLIES SD REISFELD RA
Citation: R. Xiang et al., ELIMINATION OF ESTABLISHED MURINE COLON-CARCINOMA METASTASES BY ANTIBODY-INTERLEUKIN-2 FUSION PROTEIN THERAPY, Cancer research, 57(21), 1997, pp. 4948-4955
NK-CELL MEDIATED ERADICATION OF NEUROBLASTOMA METASTASES TO BONE-MARROW BY TARGETED INTERLEUKIN-2 THERAPY
Authors: LODE HN XIANG R DREIER T GILLIES SD REISFELD RA
Citation: Hn. Lode et al., NK-CELL MEDIATED ERADICATION OF NEUROBLASTOMA METASTASES TO BONE-MARROW BY TARGETED INTERLEUKIN-2 THERAPY, Blood, 90(10), 1997, pp. 1229-1229
Risultati: 1-11 |